The prevalence of anemia and hemoglobinopathies in the hematologic clinics of the Kermanshah Province, Western Iran

International Journal of Hematology-Oncology and Stem Cell Research

Volumn 8, Issue 2, 2014, Pages 33-37

  Payandeh, Mehrdad ^a   Rahimi, Zohreh ^a   Zare, Mohammad Erfan ^a,b   Kansestani, Atefeh Nasir ^a,c   Gohardehi, Farzad ^d   Hashemian, Amir Hossein ^c  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anemia; Hemoglobinopathies; Iron deficiency anemia; thalassemia; thalassemia

Indexed keywords

CELLULOSE ACETATE; CITRIC ACID; HEMOGLOBIN C; HEMOGLOBIN D; HEMOGLOBIN DERIVATIVE; HEMOGLOBIN G; HEMOGLOBIN H; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; ALPHA THALASSEMIA; ANEMIA; ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; CHILD; FEMALE; GEL ELECTROPHORESIS; HEMATOLOGY; HEMATOLOGY CLINIC; HEMOGLOBIN ANALYSIS; HEMOGLOBIN D DISEASE; HEMOGLOBIN H DISEASE; HEMOGLOBINOPATHY; HUMAN; IRAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MICROCYTIC ANEMIA; POLYMERASE CHAIN REACTION; PREVALENCE; SICKLE CELL BETA THALASSEMIA; SICKLE CELL TRAIT;

EID: 84898751932     PISSN: 17351243     EISSN: 20082207     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Weatherall DJ.Hemoglobin and inherited Disorders of globin synthesis. In: Hoffbrand AV, Catovsky D, Tuddenham EGD. Postgraduate haematology, 5th ed. Oxford: Blackwell Scientific Publication; 2005. pp. 85-90.
2. Rahimi Z. Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran. BioMed Res Int 2013; 2013:1-10
3. Clarke GM, Higgins TN. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. ClinChem 2000; 46:1284-90.
4. Dumars KW, Boehm C, Eckman JR, et al. Practical guide to the diagnosis of thalassemia. Am J Med Gen1996; 62:29-37.
5. Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med2005; 353:1135-46.
6. Lafferty J, Waye JS, Chui DH, et al. Good practice guidelines for laboratory investigation of hemoglobinopathies. Lab Hematol2003; 9: 237-45.
7. Al-Awamy BH. Thalassemia syndromes in Saudi Arabia: Meta-analysis of local studies. Saudi Med J 2000; 21:8-17.
8. Rahimi Z, Muniz A, Parsian A. Detection of responsible mutations for beta thalassemia in the Kermanshah Province of Iran using PCR-based techniques. MolBiol Rep 2010; 37:149-54.
9. Soltani MA. Historical geography and comprehensive history of Kermanshah. Soha Press, Tehran, 1999.
10. Lafferty JD, Barth DS, Sheridan BL, McFarlane AG, Halchuk LM, Crowther MA. Prevalence of thalassemia in patients with microcytosis referred for hemoglobinopathy investigation in Ontario: a prospective cohort study. Am J Clin Pathol 2007; 127:192-6.
11. MacPherson RA, Pincus MR. Henry's clinical diagnostic and management by laboratory methods. 22nd ed. Elsevier publication; 2011.pp. 575-89.
12. Jalal S, AL-Allawi N, Faraj A, AhmedN. Prevalence of haemoglobinopathies in Sulaimani - Iraq. Dohuk Medical Journal. 2008, 2: 71-9.
13. Lafferty JD, Barth DS, Sheridan BL, McFarlane AG, Halchuk LM, Crowther MA. Prevalence of thalassemia in patients with microcytosis referred for hemoglobinopathy investigation in Ontario: a prospective cohort study. Am J Clin Pathol 2007; 127: 192-6.
14. Rahimi Z, Muniz A, Mozafari H. Abnormal hemoglobins among Kurdish population of Western Iran: hematological and molecular features. MolBiol Rep 2010; 37:51-7.
15. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, Ehsani MA, Najmabadi H, Akbari MT, Afrasiabi A, Akhavan-Niaki H, Hoorfar H. Thalassemia in Iran: epidemiology, prevention, and management. J PediatrHematolOncol 2007;29:233-8.
16. Alsaeed AH. Prevalence of Hemoglobinopathy Disorders in Adult Patients Sent for Diagnosis of Anemia in Saudi Arabia. Genet Test and Mole Biomarkers 2012; 16: 25-9.
17. Movahed A, Obeidi A, Khamisipour GR. Prevalence of hemoglobinopathies and their associations with different types of hemoglobin and mean cell volume in the pre university students of Bushehr, 2007. South Med J 2008; 12: 54-9.
18. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, Ehsani MA, Najmabadi H, Akbari MT, Afrasiabi A, Akhavan-Niaki H, Hoorfar H. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol 2007; 29:233-8.
19. Hadavi V, Taromchi AH, Malekpour M, Gholami B, Law HY, Almadani N, Afroozan F, Sahebjam F, Pajouh P, Kariminejad R, Kariminejad MH, Azarkeivan A, Jafroodi M, Tamaddoni A, Puehringer H, Oberkanins C, Najmabadi H. Elucidating the spectrum of alpha-thalassemia mutations in Iran. Haematologica 2007; 92:992-3.
20. Rahimi Z, Merat A, Gerard N, Krishnamoorthy R, Nagel RL. Implications of the genetic epidemiology of globin haplotypes linked to the sickle gene in Southern Iran. Hum Biol 2006;78:719-731.